First generic specialty injections approved for Novadoz Pharmaceuticals.
Though decreasing, initiatives and awareness will generate more revenue.
Rare instances of worsening liver function reported to FDA.
Grant-funded program to bring more opportunities for safe disposal.
New pleuromutilin antibiotic IV and oral tablets.
Humira successor indicated for adults with inadequate response or intolerance to methotrexate.
2019 cases greater than five-year trend.
Black box warns of increased risk of blood clots and death.
New program to fund community pharmacy reinvention efforts.